On the other hand, nesolicaftor (PTI-428), a CFTR amplifier, was demonstrated to reverse the CFTR inhibition caused by miR-145 mediated by TGF-β signaling in CF cells [155]. This evidence concerns the gene TGFB1 and cystic fibrosis.